AU2001273125A1 - Combinations of bisphosphonates, estrogenic agents and optionally estrogens - Google Patents
Combinations of bisphosphonates, estrogenic agents and optionally estrogensInfo
- Publication number
- AU2001273125A1 AU2001273125A1 AU2001273125A AU7312501A AU2001273125A1 AU 2001273125 A1 AU2001273125 A1 AU 2001273125A1 AU 2001273125 A AU2001273125 A AU 2001273125A AU 7312501 A AU7312501 A AU 7312501A AU 2001273125 A1 AU2001273125 A1 AU 2001273125A1
- Authority
- AU
- Australia
- Prior art keywords
- bisphosphonates
- combinations
- estrogenic agents
- estrogens
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21618800P | 2000-07-06 | 2000-07-06 | |
US21606900P | 2000-07-06 | 2000-07-06 | |
US60/216,188 | 2000-07-06 | ||
US60/216,069 | 2000-07-06 | ||
PCT/US2001/020970 WO2002003976A2 (en) | 2000-07-06 | 2001-06-29 | Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001273125A1 true AU2001273125A1 (en) | 2002-01-21 |
Family
ID=26910620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001273125A Abandoned AU2001273125A1 (en) | 2000-07-06 | 2001-06-29 | Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1299093A2 (en) |
JP (1) | JP2004502730A (en) |
CN (1) | CN1450913A (en) |
AU (1) | AU2001273125A1 (en) |
BR (1) | BR0112364A (en) |
CA (1) | CA2415052A1 (en) |
MX (1) | MXPA02012897A (en) |
WO (1) | WO2002003976A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6376486B1 (en) | 2000-07-06 | 2002-04-23 | American Home Products Corporation | Methods of inhibiting sphincter incontinence |
US6455568B2 (en) | 2000-07-06 | 2002-09-24 | Wyeth | Combination therapy for inhibiting sphincter incontinence |
AU2001271781A1 (en) * | 2000-07-06 | 2002-01-21 | Wyeth | Use of substituted indole compounds for treating sphincter incontinence |
US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
EP2526940A3 (en) | 2002-07-24 | 2014-07-30 | Children's Hospital Medical Center | Compositions containing enantiomeric equol, and methods for their making |
US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
CA2504682A1 (en) | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
RU2315603C2 (en) † | 2002-12-20 | 2008-01-27 | Ф.Хоффманн-Ля Рош Аг | Composition with high dose of ibandronat |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
CN113248494A (en) | 2015-10-01 | 2021-08-13 | 奥列马制药公司 | tetrahydro-1H-pyridine [3,4-b ] indole antiestrogens |
RU2747802C2 (en) | 2015-12-09 | 2021-05-14 | Зе Боард Оф Трастис Оф Зе Юниверсити Оф Иллинойс | Benzothiophene selective estrogen receptor blockers |
CN109562107A (en) | 2016-05-10 | 2019-04-02 | C4医药公司 | Heterocycle degron body for target protein degradation |
CN109641874A (en) | 2016-05-10 | 2019-04-16 | C4医药公司 | C for target protein degradation3The glutarimide degron body of carbon connection |
CN109562113A (en) | 2016-05-10 | 2019-04-02 | C4医药公司 | Loop coil degron body for target protein degradation |
RU2019102647A (en) | 2016-07-01 | 2020-08-03 | Г1 Терапьютикс, Инк. | PYRIMIDINE-BASED ANTIPROLIFERATING AGENTS |
WO2018081168A2 (en) | 2016-10-24 | 2018-05-03 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective mixed estrogen receptor downregulators |
CA3048057A1 (en) | 2017-01-06 | 2018-07-12 | G1 Therapeutics, Inc. | Combination therapy for the treatment of cancer |
AU2018217809A1 (en) | 2017-02-10 | 2019-08-22 | G1 Therapeutics, Inc. | Benzothiophene estrogen receptor modulators |
CA3067873A1 (en) | 2017-06-29 | 2019-01-03 | G1 Therapeutics, Inc. | Morphic forms of g1t38 and methods of manufacture thereof |
WO2020132561A1 (en) | 2018-12-20 | 2020-06-25 | C4 Therapeutics, Inc. | Targeted protein degradation |
CN114901277B (en) | 2019-12-20 | 2024-05-17 | C4医药公司 | Isoindolinone and indazole compounds for EGFR degradation |
WO2024030968A1 (en) | 2022-08-03 | 2024-02-08 | Brystol-Myers Squibb Company | Compounds for modulating ret protein |
WO2024097989A1 (en) | 2022-11-04 | 2024-05-10 | Bristol-Myers Squibb Company | Ret-ldd protein degraders |
WO2024097980A1 (en) | 2022-11-04 | 2024-05-10 | Bristol-Myers Squibb Company | Ret-ldd protein inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9911040A (en) * | 1998-05-15 | 2001-02-13 | American Home Prod | 2-phenyl-1- [4- (2-aminoethoxy) -benzyl] -indole in combination with estrogens |
CN1309637A (en) * | 1998-05-15 | 2001-08-22 | 美国家用产品公司 | Compositions comprising 2-phenyl-indole compounds and estrogen formutations |
US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
-
2001
- 2001-06-29 JP JP2002508431A patent/JP2004502730A/en active Pending
- 2001-06-29 EP EP01952365A patent/EP1299093A2/en not_active Withdrawn
- 2001-06-29 BR BR0112364-5A patent/BR0112364A/en not_active Application Discontinuation
- 2001-06-29 MX MXPA02012897A patent/MXPA02012897A/en unknown
- 2001-06-29 CA CA002415052A patent/CA2415052A1/en not_active Abandoned
- 2001-06-29 WO PCT/US2001/020970 patent/WO2002003976A2/en not_active Application Discontinuation
- 2001-06-29 AU AU2001273125A patent/AU2001273125A1/en not_active Abandoned
- 2001-06-29 CN CN01815091A patent/CN1450913A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2002003976A2 (en) | 2002-01-17 |
BR0112364A (en) | 2003-07-29 |
EP1299093A2 (en) | 2003-04-09 |
WO2002003976A3 (en) | 2003-01-03 |
JP2004502730A (en) | 2004-01-29 |
MXPA02012897A (en) | 2003-10-24 |
CA2415052A1 (en) | 2002-01-17 |
CN1450913A (en) | 2003-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273125A1 (en) | Combinations of bisphosphonates, estrogenic agents and optionally estrogens | |
AU2001243502A1 (en) | Registry emulation | |
AU2001258341A1 (en) | 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens | |
HUP0400646A3 (en) | Steroid hormone-compositions and processes for their preparation | |
AU2001246876A1 (en) | Remedies | |
AU2001246877A1 (en) | Remedies | |
AU2001243462A1 (en) | Improved thoraco-lumbo-sacral orthosis | |
MXPA02012891A (en) | Pharmaceutical compositions of estrogenic agents. | |
AU2001268341A1 (en) | System for wireless push and pull based services | |
AU2001271785A1 (en) | Combinations of statins, estrogenic agents and optionally estrogens | |
AU8382901A (en) | Sanitary fitting | |
ZA200402458B (en) | Estrogen/gestagen combination preparation and application thereof | |
AU2001288040A1 (en) | Homeostasis-maintaining agents | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU2001273074A1 (en) | Combinations of ssri and estrogenic agents | |
AU2001297914A1 (en) | Tomosynthesis system and registration method | |
AU2001280801A1 (en) | Mixer and process for use | |
EP1151667A3 (en) | Plant-activating agent | |
AU2001233208A1 (en) | Human sulfatases | |
AU4179100A (en) | Toilet deodorizer | |
EP1144431A3 (en) | 16-hydroxyestratrienes as selective estrogens | |
IL149715A0 (en) | MICROBIAL 9α-HYDROXYLATION OF STEROIDS | |
AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
AU2092200A (en) | Use of estrogens and delta-gonadien-21-ol-3,20-diones | |
AU8201601A (en) | 16alpha-methyl or ethyl substituted estrogens |